Locke JE, Mehta S, Sawinski D, Gustafson S, Shelton BA, Reed RD, MacLennan P, Bolch C, Durand C, Massie A, Mannon RB, Gaston R, Saag M, Overton T, Segev DL.
: Access to Kidney Transplantation among HIV-Infected Waitlist Candidates.
Clin J Am Soc Nephrol February 2017.
Locke JE, Sawinski D, Reed RD, Shelton B, MacLennan PA, Kumar V, Mehta S, Mannon RB, Gaston R, Julian B, Carr JJ, Terry JG, Kilgore M, Massie AB, Segev DL, Lewis CE. : APOL1 genotyping and kidney failure risk projection for the young living kidney donor candidate. Annals of Surgery January 2017.
Koyawala N, Silber JH, Rosenbaum PR, Wang W, Hill AS, Reiter JG, Nikam BA, Even-Shoshan O, Bloom RD, Sawinski D, Nazarian S, Trofe-Clark J, Lim MA, Schold J, Reese PP: Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation. Journal of the American Society of Nephrology epub 2017.
Cohen JB, Eddinger KC, Locke JE, Forde KA, Reese PP, Sawinski D.: Survival Benefit of Transplantation with a Deceased Diabetic Donor Kidney Compared to Remaining on the Waitlist. Clinical Journal of the American Society of Nephrology accepted 2017.
Eddinger KC, Cohen JB, Forde KA, Abt PL, Sawinski D.: Belatacept Compared to Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study. Transplantation December 2016 Notes: epub ahead of print.
Locke JE, Reed RD, Massie A, MacLennan PA, Sawinski D, Kumar V, Mehta S, Mannon RB, Gaston R, Lewis CE, Segev DL: Obesity and end-stage renal disease risk among living kidney donors. Kidney International December 2016 Notes: epub ahead of print.
Locke JE, Shelton B, Reed R, MacLennan PA, Mehta S, Sawinski D, Segev DL.: Identification of Optimal Donor-Recipient Combinations among HIV+ Kidney Transplant Recipients. American Journal of Transplantation August 2016.
Sawinski D, Patel N, Appolo B, Bloom RD: Use of HCV+ donors does not affect HCV clearance with directly acting antiviral therapy but shortens the wait time to kidney transplantation. Transplantation August 2016.
Sawinski D, Lee DH, Doyle AM and Blumberg EA: Successful Post-transplant Treatment of Hepatitis C with Ledipasvir-Sofosbuvir in HIV+ Kidney Transplant Recipients. Transplantation july 2016.
Shelton BA, Mehta S, Sawinski D, Reed RD, MacLennan PA, Gustafson S, Segev DL, Locke JE.: Increased Mortality and Graft Loss with Kidney Retransplantation Among Human Immunodeficiency Virus (HIV) Infected Recipients. American Journal of Transplantation June 2016.
back to top
Last updated: 03/09/2017
The Trustees of the University of Pennsylvania